A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.
Manufactured by
Singapore, Singapore
Today, doctors face the delicate challenge of making accurate diagnoses daily. However, the tools currently available to them are far from perfect. Medical practitioners often find themselves having to compromise between performance and convenience. Since 2011, Credo Diagnostics has been researching and developing revolutionary diagnostic technologies. Our mission is to create, manufacture, and commercialize accurate, rapid, and affordable molecular diagnostic platforms that can be used at Point-of-Care. We understand the importance of simplifying processes and speeding up diagnostic turnaround times, all while keeping costs low and ensuring the highest level of accuracy. That s why we provide innovative solutions for diagnosis in the field of Human Health. As a diagnostic company, we believe we have a moral responsibility and duty to doctors and patients. We strive to provide effective and rapid Point-of-Care Molecular Diagnostics that will redefine healthcare and revolutionize human clinical management. Credo Diagnostics is committed to improving the tools available to doctors, enabling them to make more accurate diagnoses efficiently and affordably. We are dedicated to advancing healthcare through our innovative molecular diagnostic platforms, ultimately enhancing patient care and outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KogeneBiotech Co., Ltd.
South Korea · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Applied Biocode, Inc.
United States · 2 relevant products
APPOLON BIOTECK SAS
France · 1 relevant product
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 2 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 3 relevant products
Healgen Scientific LLC
United States · 3 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 3 relevant products
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED
China · 1 relevant product
Vircell S.L.
Spain · 2 relevant products
65 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 111 closest product alternatives
KogeneBiotech Co., Ltd. · South Korea
Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for influenza virus detection with high sensitivity and specificity. Designed for rapid identification of influenza infections in clinical settings.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
APPOLON BIOTECK SAS · France
Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
Healgen Scientific LLC · United States
Rapid diagnostic test for simultaneous detection of influenza A/B and coronavirus antigens from nasopharyngeal or oropharyngeal specimens. CLIA-waived immunofluorescence assay enabling point-of-care results within minutes for respiratory pathogen screening and patient triage.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Utilizes Colloidal Gold Immunochromatographic Assay and Fluorescence Immunoassay technologies to support rapid antigen detection for Influenza A/B, RSV, COVID-19, ADV, HMPV, PIV, and co-infection panels. Designed for professional point-of-care testing (POCT) environments in hospital emergency departments and public health programs. Compatible with nasopharyngeal and nasal swab samples with CE-IVD compliant formats and shelf life up to 36 months at 2–30°C.
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED · China
Multiplex real-time PCR assay for simultaneous detection of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus. Facilitates rapid differential diagnosis of respiratory viral infections.
Vircell S.L. · Spain
Real-time PCR assay for screening and detection of Influenza A virus. The kit enables rapid identification of influenza A infections during seasonal epidemics and pandemic preparedness.
Coyote Bioscience Co.,Ltd · China
A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products